Breast cancer remains one of the most common cancer types in women. It is a heterogeneous disease with a number of molecular phenotypes. Advances in the field of molecular research have offered new insights into the cellular mechanisms and genetic changes that characterize breast cancer subtypes. This has allowed the identification of key driver genes and aberrations that initiate tumor development. Furthermore, the characterization of novel cellular targets has contributed to the development of improved therapeutic and diagnostic strategies.
This Special Issue on "New Insights into Breast Cancer" will gather reviews and original research articles that highlight recent advances in our understanding of the molecular basis of breast cancer, as well as novel therapeutic approaches. We invite researchers working on the personalized management of breast cancer using genomics and other biomarkers to contribute to this Special Issue. Finally, research relating to therapy resistance and novel approaches targeting tumor escape mechanisms will also be included in the scope of this Special Issue.
Prof. Nicholas Pavlidis and Dr. Stergios Boussios
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.
- Landscape of Artificial Intelligence in Breast Cancer (2000–2021): A Bibliometric AnalysisYujie Zhang, Chaoran Yu, Feng Zhao, Hua Xu, ... Yousheng LiFront. Biosci. (Landmark Ed) 2022, 27(8), 224; https://doi.org/10.31083/j.fbl270822411Download46Views
- Combined Analysis of Disseminated Tumor Cells (DTCs) and Circulating Tumor DNA (ctDNA) in a Patient Suffering from Triple Negative Breast Cancer Revealed Elevated RiskIvonne Nel, Henrike Herzog, Bahriye AktasFront. Biosci. (Landmark Ed) 2022, 27(7), 208; https://doi.org/10.31083/j.fbl270720820Download110Views
- Anti-cancer Drug Anlotinib Promotes Autophagy and Apoptosis in Breast CancerShuyi Chen, Yabiao Gao, Ping Zhu, Xue Wang, ... Ping ZhouFront. Biosci. (Landmark Ed) 2022, 27(4), 125; https://doi.org/10.31083/j.fbl270412593Download280Views